NIH-funded research Fellowship grant

How a specific protein regulation affects heart muscle growth and function

Official title: Regulation of SGK1-mediated Pathological Cardiac Hypertrophy by Non-Canonical ERAD

Funded at University of Arizona · NIH-10995585 · Data updated 2026-11-12

This study is looking at how a protein called SGK1 affects the heart when it gets too big due to high blood pressure, and it aims to find new ways to keep hearts healthy and prevent heart failure, which could help patients with heart conditions.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startDecember 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$40,591
NIH project number1F31HL172675-01A1
Project IDNIH-10995585 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of hypertension or early signs of cardiac hypertrophy.

Less likely to help

Patients with non-cardiac related health issues or those without any signs of heart disease may not benefit from this research.

What this research studies

This research investigates the role of a protein called SGK1 in the development of pathological cardiac hypertrophy, which is an abnormal enlargement of the heart muscle often caused by high blood pressure. The study focuses on understanding how the body manages protein levels in heart cells, particularly how misfolded proteins are recognized and degraded. By exploring the mechanisms of protein degradation in heart cells, the research aims to uncover new insights into maintaining heart health and preventing heart failure. Patients may benefit from findings that could lead to new treatments for heart conditions related to abnormal heart muscle growth.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating heart failure caused by pathological cardiac hypertrophy.

How similar studies have gone: Previous research has shown promising results in understanding protein degradation mechanisms in heart diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Bagchi, Sukriti — University of Arizona
  • Study coordinator: Bagchi, Sukriti

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.